CD19 CAR T-Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice Through Induction of Host Immunity

Molecular Therapy - Oncolytics - United Kingdom
doi 10.1016/j.omto.2017.12.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Enrichment of Foxp3+ CD4 Regulatory T Cells in Migrated T Cells to IL-6- And IL-8-Expressing Tumors Through Predominant Induction of CXCR1 by IL-6

Journal of Immunology
AllergyImmunology
2010English

CAR-T Cells Beyond CD19, UnCAR-Ted Territory

American Journal of Hematology
Hematology
2019English

Collaboration of Chimeric Antigen Receptor (CAR)-expressing T Cells and Host T Cells for Optimal Elimination of Established Ovarian Tumors

OncoImmunology
OncologyAllergyImmunology
2013English

Toxicities of CD19 CAR-T Cell Immunotherapy

American Journal of Hematology
Hematology
2019English

High Rate of Durable Complete Remission in Follicular Lymphoma After Cd19 Car-T Cell Immunotherapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Oncolytic Virus Expressing RANTES and IL-15 Enhances Function of CAR-modified T Cells in Solid Tumors

OncoImmunology
OncologyAllergyImmunology
2015English

CML Hematopoietic Stem Cells Expressing IL-1RAP Can Be Targeted by Chimeric Antigen Receptor (CAR)-engineered T Cells

Cancer Research
Cancer ResearchOncology
2018English

Genetically Targeted T Cells Eradicate Established Breast Cancer in Syngeneic Mice

Clinical Cancer Research
Cancer ResearchOncology
2009English

IL-21 Promotes Pulmonary Fibrosis Through the Induction of Profibrotic CD8+ T Cells

Journal of Immunology
AllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy